During the past decade, Lynn Cancer Institute conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 44 clinical trials were completed, i.e. on average, 118.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 16 clinical trials were completed. i.e. 177.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lynn Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Radiation Therapy Oncology Group" with 7 trials sponsored, "Eastern Cooperative Oncology Group" with 6 trials sponsored and "Genentech, Inc." with 6 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lynn Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Lynn Cancer Institute" are "Breast Cancer" (10 trials), "Colorectal Cancer" (8 trials), "Non-Small Cell Lung Cancer" (7 trials), "Lung Cancer" (6 trials) and "Pancreatic Cancer" (6 trials). Many other conditions were trialed in "Lynn Cancer Institute" in a lesser frequency.

Most popular intervention types in "Lynn Cancer Institute" are "Drug" (87 trials), "Biological" (21 trials), "Radiation" (17 trials), "Other" (14 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Bevacizumab" (8 trials), "fluorouracil" (8 trials), "radiation therapy" (8 trials) and "cisplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Lynn Cancer Institute" are 87 trials for "All" genders, 9 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Lynn Cancer Institute". undefined are not yet recruiting, 6 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 65 completed trials in Lynn Cancer Institute, 2 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Lynn Cancer Institute, 5 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".